AUTHOR=Schneider Francis , Le Borgne Pierrick , Herbrecht Jean-Etienne , Danion François , Solis Morgane , Hellé Sophie , Betscha Cosette , Clere-Jehl Raphaël , Lefebvre François , Castelain Vincent , Goumon Yannick , Metz-Boutigue Marie-Hélène TITLE=Assessment of plasma Catestatin in COVID-19 reveals a hitherto unknown inflammatory activity with impact on morbidity-mortality JOURNAL=Frontiers in Immunology VOLUME=Volume 13 - 2022 YEAR=2022 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.985472 DOI=10.3389/fimmu.2022.985472 ISSN=1664-3224 ABSTRACT=ABSTRACT 246 words Introduction Neuroendocrine cells release Catestatin (Cts) from Chromogranin A (CgA) to regulate stress responses. As regards COVID-19 patients (COVID+) requiring oxygen supply, to date nobody has studied Cts as a potential mediator in the regulation of immunity. Patients & Methods Admission plasma Cts and CgA - its precursor - concentrations were measured (Elisa test) in 73 COVID+ and 27 controls. Relationships with demographics, comorbidities, disease severity and outcomes were analysed (Mann-Witney, Spearman correlation tests, ROC curves). Results Among COVID+, 49 required ICU-admission (COVID+ICU+) and 24 standard hospitalization (COVID+ICU-). Controls were either healthy staff (COVID-ICU-, n=11) or COVID-ICU+ patients (n=16). Median plasma Cts were higher in COVID+ than in controls (1.6 [1.02; 3.79] vs 0.87 [0.59; 2.21] ng/mL, p<0.03), with no difference between COVID+ and COVID-ICU+. There was no difference between groups in either CgA or Cts/CgA ratios, but these parameters were lower in healthy controls (p<0.01). Cts did not correlate with either hypoxia- or usual inflammation-related parameters. In-hospital mortality was similar whether COVID+ or not, but COVID+ had longer oxygen support and more complications (p<0.03). Cts concentrations and the Cts/CgA ratio were associated with in-hospital mortality (p<0.01) in COVID+, whereas CgA was not. CgA correlated with care-related infections (p<0.001). Conclusion: Respiratory COVID patients release significant amounts of Cts in the plasma making this protein widely available for the neural regulation of immunity. If confirmed prospectively, plasma Cts will reliably help in predicting in-hospital mortality, whereas CgA will facilitate the detection of patients prone to care-related infections.